Colon carcinogenesis is a complex, multi-step process involving progressive changes in intestinal epithelial cell proliferation, differentiation and programmed death. Our long-term goal is to understand the role of protein kinase C (PKC) isozymes in intestinal epithelial cell biology and colon carcinogenesis. Several lines of evidence suggest that the PKC betaII isozyme (PKC betaII) is involved in colon carcinogenesis. First, PKC betaII levels and activity are elevated in colon carcinomas compared to normal colonic epithelium. Second, PKC betaII is involved in colon carcinoma cell proliferation in vitro. Third, components of a high fat diet can potently stimulate intestinal epithelial cell PKC betaII activity and promote colon carcinogenesis. Based on these findings, and our preliminary studies, we hypothesize that PKC betaII is directly involved in colon carcinogenesis. To directly test this hypothesis, we developed transgenic mice that express elevated PKC betaII levels in the intestinal epithelium. In preliminary studies, these mice exhibit evidence of colonic epithelial hyperproliferation and an increased susceptibility to carcinogen-induced colon cancer. In this application we propose four specific aims to: 1) characterize three transgenic PKC betaII lines for transgene copy number, tissue distribution, expression level and activity of the PKC betaII transgene, and for changes in intestinal epithelial cytokinetics; 2) assess whether transgenic PKC betaII mice exhibit increased susceptibility to carcinogen-induced colon cancer; 3) determine whether a high fat diet enhances the susceptibility of transgenic PKC betaII mice to colon cancer; and 4) determine whether elevated PKC betaII expression synergizes with loss-of-function mutation of the APC tumor suppressor gene in promoting intestinal tumorigenesis in the APCmin mouse model. These studies will allow the first direct analysis of the role of PKC betaII in colon cancer in two relevant animal models of the human disease.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
7R01CA081436-06
Application #
6791686
Study Section
Metabolic Pathology Study Section (MEP)
Program Officer
Poland, Alan P
Project Start
1999-04-02
Project End
2004-06-30
Budget Start
2003-09-18
Budget End
2004-06-30
Support Year
6
Fiscal Year
2003
Total Cost
$648,014
Indirect Cost
Name
Mayo Clinic, Jacksonville
Department
Type
DUNS #
153223151
City
Jacksonville
State
FL
Country
United States
Zip Code
32224
Wang, Y; Justilien, V; Brennan, K I et al. (2017) PKC? regulates nuclear YAP1 localization and ovarian cancer tumorigenesis. Oncogene 36:534-545
Justilien, Verline; Ali, Syed A; Jamieson, Lee et al. (2017) Ect2-Dependent rRNA Synthesis Is Required for KRAS-TRP53-Driven Lung Adenocarcinoma. Cancer Cell 31:256-269
Fields, Alan P; Ali, Syed A; Justilien, Verline et al. (2017) Targeting oncogenic protein kinase C? for treatment of mutant KRAS LADC. Small GTPases 8:58-64
Fields, Alan P; Justilien, Verline; Murray, Nicole R (2016) The chromosome 3q26 OncCassette: A multigenic driver of human cancer. Adv Biol Regul 60:47-63
Ali, Syed A; Justilien, Verline; Jamieson, Lee et al. (2016) Protein Kinase C? Drives a NOTCH3-dependent Stem-like Phenotype in Mutant KRAS Lung Adenocarcinoma. Cancer Cell 29:367-378
Fields, Alan P; Ali, Syed A; Murray, Nicole R (2016) Oncogenic PKC? decides tumor-initiating cell fate. Cell Cycle 15:2383-4
Murray, Nicole R; Justilien, Verline; Fields, Alan P (2016) SOX2 Determines Lineage Restriction: Modeling Lung Squamous Cell Carcinoma in the Mouse. Cancer Cell 30:505-507
Liou, Geou-Yarh; Döppler, Heike; Braun, Ursula B et al. (2015) Protein kinase D1 drives pancreatic acinar cell reprogramming and progression to intraepithelial neoplasia. Nat Commun 6:6200
Butler, Amanda M; Scotti Buzhardt, Michele L; Erdogan, Eda et al. (2015) A small molecule inhibitor of atypical protein kinase C signaling inhibits pancreatic cancer cell transformed growth and invasion. Oncotarget 6:15297-310
Justilien, Verline; Fields, Alan P (2015) Molecular pathways: novel approaches for improved therapeutic targeting of Hedgehog signaling in cancer stem cells. Clin Cancer Res 21:505-13

Showing the most recent 10 out of 53 publications